Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.85    0.10 (3.64%)
Bid:
2.75
Ask:
2.85
Spread: 0.10 (3.636%)
Market Cap: £5.20m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Milestone Achieved

24 Dec 2018 07:00

RNS Number : 3583L
Nanoco Group PLC
24 December 2018
 

24 December 2018

 

NANOCO GROUP PLC

("Nanoco" or the "Group")

 

Milestone Achieved

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, today announces that it has completed a significant milestone established as part of the Material Development and Supply Agreement announced in February 2018 with its undisclosed US Customer (the "US Company").

This milestone (the third of three) has been completed within with the timetable set out in the agreement and reflects the significant progress being made. The total value of all milestones in this programme triggered to date is £4.2m with this third milestone valued at £1.6m.

Michael Edelman, Chief Executive of Nanoco, said:

 

"We are pleased to announce the delivery of the third and final milestone for our US Customer. We continue to discuss other potential services and deliverables and our aim is to deepen and lengthen our relationship with this important collaboration."

 

- Ends -

For further information, please contact:

Nanoco Group PLC:

Brian Tenner, COO & CFO +44 (0) 161 603 7900

Caroline Watson, Investor Relations Manager +44 (0) 7788 897 357

cwatson@nanocotechnologies.com

MHP Communications: +44 (0) 203 128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFIDFRLVFIT
Date   Source Headline
31st Jul 20127:00 amRNSSigns Joint Development Agreement
27th Jul 20127:00 amRNSExercise of Options
25th Jun 20127:00 amRNSChange of Adviser
9th May 20127:00 amRNSAchieves US$2m Milestone
2nd Apr 20122:15 pmRNSTotal Voting Rights
28th Mar 20127:00 amRNSExercise of Options
26th Mar 20127:00 amRNSInterim Results
14th Feb 20127:00 amRNSSigns Joint Development Agreement
10th Feb 20128:56 amRNSHolding(s) in Company
7th Feb 20128:58 amRNSHolding(s) in Company
7th Feb 20128:55 amRNSHolding(s) in Company
31st Jan 20127:00 amRNSAchieves US$1m Milestone
25th Jan 20124:40 pmRNSSecond Price Monitoring Extn
25th Jan 20124:35 pmRNSPrice Monitoring Extension
20th Jan 20124:40 pmRNSSecond Price Monitoring Extn
20th Jan 20124:35 pmRNSPrice Monitoring Extension
20th Jan 20127:00 amRNSNotification of Results
13th Jan 20124:35 pmRNSPrice Monitoring Extension
16th Dec 201111:12 amRNSResult of AGM
16th Dec 20117:00 amRNSAGM Statement
6th Dec 201111:16 amRNSTotal Voting Rights - Voting Rights and Capital
29th Nov 20114:21 pmRNSHolding(s) in Company
29th Nov 20117:00 amRNSGrant of Options and Directors' Dealings
22nd Nov 20117:00 amRNSDirector/PDMR Shareholding
16th Nov 20117:00 amRNSAnnual Report & Accounts
15th Nov 20112:49 pmRNSHolding(s) in Company
17th Oct 20117:00 amRNSPreliminary Results
3rd Oct 20117:00 amRNSTokyo Electron
9th Sep 20117:00 amRNSNotification of Results
15th Aug 20118:21 amRNSHolding(s) in Company
12th Aug 20117:00 amRNSJoint Development Agreement
28th Jul 20117:00 amRNSAppointment of Nomad
15th Jul 20114:22 pmRNSHolding(s) in Company
30th Jun 20117:00 amRNSApplication for Admission
3rd Jun 20117:00 amRNSDirector/PDMR Shareholding
27th May 201110:53 amRNSIssue of Equity
5th Apr 20117:00 amRNSDevelopment Agreement
4th Apr 20117:00 amRNSInterim Results
1st Apr 20117:00 amRNSAchieves US$2m Milestone
25th Mar 20119:50 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSNotification of Interim Results
7th Feb 20114:33 pmRNSHolding(s) in Company
4th Feb 20114:35 pmRNSHolding(s) in Company
28th Jan 20117:00 amRNSPlacing Raises £15 million
27th Jan 20113:01 pmRNSProposed Placing
27th Jan 20113:00 pmRNSRuncorn Commissioning
14th Jan 20113:18 pmRNSIssue of Equity
17th Dec 20107:00 amRNSMilestone Payment
10th Dec 201011:51 amRNSResult of AGM
10th Dec 20107:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.